Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.

Lilly may be impacted by Novartis' pelacarsen flop -- but not by much.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Monday 14 September →